Contents 1. Statement of Purpose 4 2. Terms of Reference for the Group 14-1C-101g 4 14-1C-101g 3. Structure and Function 5 3.1 Role and Function of the Group 5 3.2 Network Configuration 14-1C-101g 6 14-1C-101g, 14-1C-102g 3.3 Network Group Members 6 Local Urological Cancer Teams 3.4 14-1C-101g, 14-1C-102g 8 Specialist Urological Cancer Teams 3.5 9 14-1C-101g, 14-1C-102g Network Group Membership 3.6 14-1C-102g, 14-1C-103g 9 3.7 Group Meetings 14-1C-103g 9 3.8 14-1C-104g 10 Work Programme and Annual Report Coordination of Care/Patient Pathway 4. 10 Primary Care Referral Guidelines 4.1 10 Referral Guidelines for Patients moving between 4.2 10 Teams Clinical Guidelines 4.3 11 Clinical Guidelines for Kidney Cancer 4.3.1 14-1C-105g 11 Clinical Guidelines for Bladder Cancer 4.3.2 14-1C-106g 11 Clinical Guidelines for Prostate Cancer 4.3.3 14-1C-107g 11 Clinical Guidelines for Testicular Cancer 4.3.4 14-1C-108g 11 Clinical Guidelines for Penile Cancer 4.3.5 14-1C-109g 11 Chemotherapy Treatment Algorithms 4.3.6 14-1C-110g 11 Patient Pathways for Kidney Cancer 4.4 14-1C-111g 12 Patient Pathways for Bladder Cancer 4.4.1 14-1C-112g 12 Patient Pathways for Prostate Cancer 4.4.2 14-1C-113g 12 Patient Pathways for Testicular Cancer 4.4.3 14-1C-114g 12 Patient Pathways for Penile Cancer 4.4.4 14-1C1-115g 12 Patient Experience 5. 14-1C-116g 12 Clinical Outcomes/Indicators 6. 12 Clinical Outcomes Indicators and Audits 6.1 14-1C-117g 12 Discussion of Clinical Trials 6.2 12 14-1C-118g Data Collection 7. 12 Network-wide Minimum Data Set 7.1 12 Network Policy on collection of MDS 7.2 12 Distribution of Guidelines & Protocols 8. 13 Terms of Reference App 1 14
Contents 1. Statement of Purpose 4 2. Terms of Reference for the Group 14-1C-101g 4 3. Structure and Function 14-1C-101g 5 3.1 Role and Function of the Group 5 3.2 Network Configuration 14-1C-101g 6 3.3 Network Group Members 14-1C-101g, 14-1C-102g 6 3.4 Local Urological Cancer Teams 14-1C-101g, 14-1C-102g 8 3.5 Specialist Urological Cancer Teams 14-1C-101g, 14-1C-102g 9 3.6 Network Group Membership 14-1C-102g, 14-1C-103g 9 3.7 Group Meetings 14-1C-103g 9 3.8 Work Programme and Annual Report 14-1C-104g 10 4. Coordination of Care/Patient Pathway 10 4.1 Primary Care Referral Guidelines 10 4.2 Referral Guidelines for Patients moving between Teams 10 4.3 Clinical Guidelines 11 4.3.1 Clinical Guidelines for Kidney Cancer 14-1C-105g 11 4.3.2 Clinical Guidelines for Bladder Cancer 14-1C-106g 11 4.3.3 Clinical Guidelines for Prostate Cancer 14-1C-107g 11 4.3.4 Clinical Guidelines for Testicular Cancer 14-1C-108g 11 4.3.5 Clinical Guidelines for Penile Cancer 14-1C-109g 11 4.3.6 Chemotherapy Treatment Algorithms 14-1C-110g 11 4.4 Patient Pathways for Kidney Cancer 14-1C-111g 12 4.4.1 Patient Pathways for Bladder Cancer 14-1C-112g 12 4.4.2 Patient Pathways for Prostate Cancer 14-1C-113g 12 4.4.3 Patient Pathways for Testicular Cancer 14-1C-114g 12 4.4.4 Patient Pathways for Penile Cancer 14-1C1-115g 12 5. Patient Experience 14-1C-116g 12 6. Clinical Outcomes/Indicators 12 6.1 Clinical Outcomes Indicators and Audits 14-1C-117g 12 6.2 Discussion of Clinical Trials 14-1C-118g 12 7. Data Collection 12 7.1 Network-wide Minimum Data Set 12 7.2 Network Policy on collection of MDS 12 8. Distribution of Guidelines & Protocols 13 App 1 Terms of Reference 14
PCN_Urology_NSSG_Constitution_2015-draft-SB.docx